Lionsgate Studios enters July with an unusual tension: the stock is up on the month yet options traders have just flipped to their most defensive posture on record.
The options signal is the standout this week. The put/call ratio hit 0.44 on June 30 — its 52-week high and nearly two standard deviations above its 20-day average of 0.29. That shift is abrupt and concentrated: the PCR ran below 0.24 for most of May and the first three weeks of June, then jumped sharply after June 23. Something changed in the way options market participants are hedging LION.
Short interest adds a complementary cautionary note. Shares short rose roughly 16% over the week to 15.2 million, reversing a steady bleed that had knocked the position down from around 18.7 million shares in late May. The borrow market remains genuinely loose — availability is running at roughly 623%, well above its 52-week low of 471%, meaning there is ample capacity for further short building without stress. Borrowing cost is 0.52%, barely changed on a month-on-month basis and well within normal range. The picture here is one of modest, orderly re-accumulation rather than any squeeze dynamic.
The Street leans constructive, but not uniformly. B. Riley initiated coverage this week with a Neutral rating and a $17 target, landing essentially in line with current consensus. Baird raised its target to $20 (from $18) in mid-June, maintaining Outperform — one of the more bullish voices on the name. Benchmark has also lifted twice in two months, now at $17 with a Buy. The mean consensus target is $15.40, barely above the $15.31 close, though the Baird and Benchmark positions suggest the bull camp sees more room. The bull case centres on trailing twelve-month library revenues reaching $1 billion and a 31% sequential backlog increase to $1.6 billion. Bears point to a 15% year-on-year OIBDA decline in fiscal 2025, stalled STARZ growth, and a valuation that looks stretched on earnings — the PE is running around 41.6x with negative book value. EPS momentum factor scores rank in the 94th-95th percentile, signalling the earnings revision trend has been strongly upward even as absolute profitability disappoints. The short score of 51 is mid-range and little changed.
Institutional ownership shows a couple of flows worth noting. FMR (Fidelity) added over 10 million shares in the most recent filing period, bringing its stake to 5.1% — a material accumulation for a mid-sized content studio. Both Vanguard entities reported new positions established in Q1, adding a combined 20.9 million shares. On the insider side, CEO Jon Feltheimer sold 348,896 shares on May 20 at $12.43 — a $4.3 million disposal — alongside similar-scale sells by the COO and General Counsel, all tied to award exercises. Those transactions were all at prices roughly 19% below the current level, which limits the negative read.
The next earnings print is August 6. With options at their most defensive reading of the past year, short interest rebuilding after a month of decline, and the stock up 6.7% over the past month, the August report sets up as a genuine tension point between improving consensus estimates and a market that is paying more for protection than at any point in recent history.
See the live data behind this article on ORTEX.
Open LION on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
